-
Dextromethorphan hydrobromide Workflows
2026-08-12
Build reproducible excitotoxicity and ion-channel assays with Dextromethorphan hydrobromide, from solvent handling to calcium-flux validation. The guide also shows how to separate product-specific neuroscience evidence from methodological insights borrowed from a distinct PDK4 inhibitor study.
-
Oligo (dT) 25 Beads for mRNA Workflows
2026-08-12
Oligo (dT) 25 Beads enable selective polyA tail mRNA capture from eukaryotic samples while supporting either direct first-strand cDNA synthesis or purified-mRNA workflows. This guide translates the NSD1–PPARγ–PTEN findings in endometrial cancer into practical transcript-isolation, assay-design, and troubleshooting decisions.
-
Lovastatin Workflow for Mechanism-Driven Research
2026-08-11
Build pathway-first experiments with Lovastatin, from HMG-CoA reductase inhibition and cancer research to fibroblast apoptosis and macrophage efferocytosis. This guide combines practical dosing, assay controls, and a cross-domain strategy for separating metabolic effects from downstream cell phenotypes.
-
Everolimus (RAD001): From mTOR Biology to Translation
2026-08-11
Everolimus (RAD001) is more than a pathway reagent: it is a translational probe for separating mTOR-linked growth arrest from cell death. This guide connects mechanism, assay design, model selection, and clinical relevance for cancer researchers.
-
2X Taq PCR Master Mix for Beetle Colony Studies
2026-08-10
Pair spatially resolved ambrosia beetle sampling with a direct-loading PCR workflow for faster detection of host, symbiont, and pathogen DNA. This practical guide shows how a dye-containing Taq formulation can support genotyping, colony mapping, confirmation assays, and TA cloning without adding a separate gel-loading step.
-
Genistein Workflows for Mechanotransduction Research
2026-08-09
Genistein enables a controlled way to interrogate growth-factor kinase signaling alongside mechanically induced autophagy. This workflow connects concentration-response testing, cytoskeletal controls, imaging, immunoblotting, and cancer-focused phenotyping while keeping cytotoxicity and solvent effects visible.
-
Precision PCR for Neurogenetics Translation
2026-08-08
A mechanistic and strategic guide to using high-fidelity PCR when neurogenetics studies must connect environmental signaling, sequence accuracy, and translational reproducibility.
-
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO)
2026-08-07
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) helps limit endogenous proteolysis during cell and tissue extraction, including workflows that feed into mass spectrometry. It should not be treated as a complete metalloproteinase or phosphatase-control system without separate validation, and EDTA may be required when metalloproteinase activity is a concern.
-
Scenario-Based Solutions with Phos binding reagent (Phosbind
2026-08-07
This scientific article provides scenario-driven guidance for using Phos binding reagent (Phosbind) acrylamide (SKU F4002) in protein phosphorylation analysis. Integrating real laboratory challenges, quantitative evidence, and vendor selection insights, we demonstrate how this phosphate-binding reagent enables reproducible, antibody-free SDS-PAGE detection of phosphorylation states, addressing key workflow reliability and sensitivity needs.
-
KPT-330 (Selinexor): Applied CRM1 Inhibition in Cancer Resea
2026-08-06
KPT-330 (Selinexor) empowers researchers to precisely dissect nuclear export mechanisms, drive apoptosis, and suppress tumor growth in both cancer and bone disease models. This article delivers actionable protocols, workflow enhancements, and troubleshooting insights for leveraging APExBIO’s KPT-330 as a gold-standard CRM1 inhibitor.
-
Bergenin Targets γδT17 Cells via PPARγ–PROX1 Axis in Psorias
2026-08-06
This study uncovers a novel immunometabolic mechanism wherein bergenin, a plant-derived PPARγ agonist, ameliorates psoriasis by inducing ubiquitin-mediated degradation of PROX1 in γδT17 cells. These findings highlight new therapeutic targets for chronic inflammatory skin diseases and deepen our understanding of γδT17 cell regulation.
-
FGFR3 Inhibition Ameliorates SLC26A2 Chondrodysplasia in Mic
2026-08-05
This study demonstrates that pharmacological inhibition of FGFR3 signaling using NVP-BGJ398 phosphate significantly improves cartilage and bone development in mouse models of SLC26A2-related chondrodysplasia. The findings offer robust genetic and pharmacological evidence for targeting FGFR3 as a potential therapeutic strategy in rare skeletal disorders.
-
HMGCS2 Downregulation Drives LysoPC-Mediated Pulmonary Fibro
2026-08-05
Yang et al. (2024) demonstrate that downregulation of HMGCS2 in alveolar type II epithelial cells alters lipid metabolism, leading to elevated 14:0 Lyso-PC release and subsequent fibroblast activation in pulmonary fibrosis. This mechanistic insight clarifies the origin and signaling impact of lysophospholipids in fibrotic lung disease, suggesting new targets for intervention and refined models for lipid signaling pathway analysis.
-
iRhom2's Role in Olfactory Adaptation and Odorant Receptor R
2026-08-04
The referenced study uncovers how iRhom2, a regulatory protein, modulates olfactory receptor expression and activity-dependent adaptation in sensory neurons. These findings reveal a feedback mechanism linking odor exposure to dynamic olfactory gene regulation, with implications for understanding GPCR-mediated signaling in sensory biology.
-
IDH2-Driven α-Ketoglutarate and HIF-1α Dynamics in CRC Progr
2026-08-04
The reference study reveals how elevated IDH2 expression in colorectal cancer drives metabolic reprogramming by modulating α-ketoglutarate levels and HIF-1α signaling, ultimately promoting tumor progression. These mechanistic insights clarify a metabolic vulnerability in CRC and provide direction for future research targeting hypoxia pathways.